$NVRO NEVRO CORP Insider Trading Week 33/2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEVRO CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEVRO CORP in week 33/2016.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 96.16 | 661 | 63,559 | 29,142 | 29.8 K to 29.1 K (-2.22 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 96.16 | 29,953 | 2,880,143 | 1,319,816 | 1.3 M to 1.3 M (-2.22 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 97.06 | 73 | 7,086 | 29,803 | 29.9 K to 29.8 K (-0.24 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 96.02 | 457 | 43,880 | 29,876 | 30.3 K to 29.9 K (-1.51 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 97.06 | 3,327 | 322,932 | 1,349,769 | 1.4 M to 1.3 M (-0.25 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 96.02 | 20,689 | 1,986,494 | 1,353,096 | 1.4 M to 1.4 M (-1.51 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 98.66 | 121 | 11,938 | 30,333 | 30.5 K to 30.3 K (-0.40 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 97.90 | 2,039 | 199,617 | 30,454 | 32.5 K to 30.5 K (-6.28 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 98.66 | 5,487 | 541,339 | 1,373,785 | 1.4 M to 1.4 M (-0.40 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 97.90 | 92,353 | 9,041,331 | 1,379,272 | 1.5 M to 1.4 M (-6.28 %) |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 18.00 | 5,047 | 90,846 | 46,852 | |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 3.60 | 2,374 | 8,546 | 42,430 | |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 3.60 | 79 | 284 | 62,861 | |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 98.85 | 100 | 9,885 | 30,000 | 30.1 K to 30 K (-0.33 %) |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 98.09 | 3,194 | 313,286 | 30,100 | 33.3 K to 30.1 K (-9.59 %) |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 97.39 | 4,206 | 409,620 | 33,294 | 37.5 K to 33.3 K (-11.22 %) |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 18.00 | 5,047 | 90,846 | 37,500 | 32.5 K to 37.5 K (+15.55 %) |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 3.60 | 2,374 | 8,546 | 32,453 | 30.1 K to 32.5 K (+7.89 %) |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 3.60 | 79 | 284 | 30,079 | 30 K to 30.1 K (+0.26 %) |